Canada's main stock index opened lower on Tuesday, despite foreseeing an eighth straight quarter of gains, as higher commodity prices and easing geopolitical tensions lifted sentiment. The TSX ...

FCEL, PLUG, and BE are tumbling despite fresh bullish catalysts, with profit-taking after massive 2026 runs driving the broad fuel cell selloff. Bloom Energy's Brookfield AI infrastructure partnership ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

This transcript was prepared by a transcription service. This version may not be in its final form and may be updated. Imani Moise: Here's your Closing Bell Brief for Tuesday, July 7th. I'm Imani ...

An announcement from Surefire Resources NL ( (AU:SRN)) is now available. Surefire Resources has signed a Heads of Agreement with Australian Flow Batteries to test vanadium concentrate from its Victory ...

June 30 : Oaktree-backed ITG said on Tuesday it had priced its U.S. initial public offering at $16 per share, below its targeted range, raising $312.2 million. The digital infrastructure firm sold ...

When you have breast cancer, your doctor may remove some or all of the cancer tissue through a biopsy or surgery. Then, they’ll order tests of these cells to help them learn more about the cancer. One ...

SAN FRANCISCO, June 25 : Memory chipmakers have for decades been trapped in boom-bust cycles, with capacity buildouts hitting the market just as demand craters. Micron, Samsung and SK Hynix are now ...

[SINGAPORE] The Asia-Pacific recorded the slowest growth in personal wealth in 2025, as the depreciation of the US dollar impacted wealth growth in regions with appreciating currencies. Growth in ...

A B-2 Spirit launches from the runway during an exercise at Whiteman Air Force Base, Mo., Nov. 8, 2015. The B-2 Spirit is a multi-role bomber capable of delivering both conventional and nuclear ...

・Capricor Hope-2 extension study showed Deramiocel continued to slow disease progression over five years. ・The therapy also maintained stable cardiac function throughout the study. ・The company said ...